Chr. Hansen Holding A/S (CHYHY) Research

Chr. Hansen Holding A/S, a distinguished bioscience enterprise headquartered in Hørsholm, Denmark, since its establishment in 1843, focuses on crafting natural ingredient solutions. These solutions cater to a global market spanning Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific, addressing the needs of the food, nutritional, pharmaceutical, and agricultural industries. The company's activities are structured into two principal divisions. The Food Cultures & Enzymes segment provides an array of cultures, enzymes, and probiotic products. These are instrumental in defining the taste, aroma, texture, shelf life, and overall nutritional and health benefits of various consumer food items, with a strong emphasis on the dairy sector. Concurrently, the Health & Nutrition segment develops and distributes products for diverse industries including dietary supplements, over-the-counter pharmaceuticals, infant formula, animal feed, and plant protection. A notable strategic collaboration within this segment is with UPL Ltd., aimed at developing and bringing to market microbial-based bio-solutions that promote sustainable agriculture.

Open Chr. Hansen Holding A/S (CHYHY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.